Familial interstitial lung disease in children: response to chloroquine treatment in one sibling with desquamative interstitial pneumonitis. 1997

N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.

We describe a male infant with biopsy-confirmed interstitial lung disease (ILD) who responded to chloroquine, after he failed to improve on oral corticosteroids or cyclophosphamide. The infant presented at 8 days of age with respiratory distress and cyanosis. Lung biopsy at 8 weeks of age was consistent with desquamative interstitial pneumonitis (DIP). He was treated with corticosteroids at 2 weeks of age because of a family history of two siblings who died during infancy and who had DIP on postmortem examination. At 8.5 months, our patient was treated with cyclophosphamide because of lack of response to corticosteroids therapy. At 14 months of age, he began treatment with chloroquine in addition to corticosteroids and had a dramatic response within 3 weeks. The patient has been maintained successfully on continuous treatment with chloroquine alone for more than 9 years since this treatment was started.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017563 Lung Diseases, Interstitial A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. Diffuse Parenchymal Lung Disease,Diffuse Parenchymal Lung Diseases,Interstitial Lung Disease,Interstitial Lung Diseases,Pneumonia, Interstitial,Pneumonitis, Interstitial,Interstitial Pneumonia,Interstitial Pneumonias,Interstitial Pneumonitides,Interstitial Pneumonitis,Lung Disease, Interstitial,Pneumonias, Interstitial,Pneumonitides, Interstitial

Related Publications

N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
February 1980, Chest,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
January 1987, American journal of medical genetics. Supplement,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
January 1987, Archives of disease in childhood,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
April 1978, Chest,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
December 1994, Pediatric pulmonology,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
December 1998, Anaesthesia and intensive care,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
April 1985, Clinical pediatrics,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
March 1982, Chest,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
August 1985, Journal of pediatric gastroenterology and nutrition,
N Balasubramanyan, and A Murphy, and J O'Sullivan, and E J O'Connell
June 1994, Pediatric pulmonology,
Copied contents to your clipboard!